The University of South Florida and Tampa-based Saneron-CCEL Therapeutics Inc. will receive $2.6 million from the National Institutes of Health over the next three years for their work on treatments for Alzhimer's disease.
Continue reading your article with a Business Observer subscription.
What's included:
✓ Unlimited digital access to BusinessObserverFL.com
✓ E-Newspaper app, digital replica of print edition